WallStSmart
ATAI

ATAI Life Sciences BV

NASDAQ: ATAI · HEALTHCARE · BIOTECHNOLOGY

$4.12
-4.85% today

Updated 2026-04-29

Market cap
$1.51B
P/E ratio
P/S ratio
369.70x
EPS (TTM)
$-2.91
Dividend yield
52W range
$1 – $7
Volume
6.2M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$13.92
+237.86%
12-Month target
Intrinsic (DCF)
$7.66
Margin of safety
+48.17%
2 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 1,773.00% QoQ
+ 48.17% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-48.25M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$233000.00$314000.00$308000.00$4.09M$4.09M
Net income$-152.38M$-40.22M$-149.27M$-660.05M$-544.81M
EPS$-2.91
Free cash flow$-105.49M$-84.71M$-82.53M$-103.58M$-48.25M
Profit margin-65,401.29%-12,810.19%-48,463.96%-16,142.02%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
ATAI$1.51B257.32.56.75.0+48.17%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

ATAI Life Sciences BV trades at $4.12. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $4.09M. Our DCF model estimates intrinsic value at $7.66.

Frequently asked questions

What is ATAI Life Sciences BV's stock price?
ATAI Life Sciences BV (ATAI) trades at $4.12.
Is ATAI Life Sciences BV overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $7.66.
What is the price target of ATAI Life Sciences BV (ATAI)?
The analyst target price is $13.92, representing +237.9% upside from the current price of $4.12.
What is the intrinsic value of ATAI Life Sciences BV (ATAI)?
Based on our DCF model, intrinsic value is $7.66, a +48.2% margin of safety versus $4.12.
What is ATAI Life Sciences BV's revenue?
TTM revenue is $4.09M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio369.70x
ROE-390.00%
Beta1.57
50D MA$3.88
200D MA$4.25
Shares out0.37B
Float0.30B
Short ratio
Avg volume6.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years